Form 4: Axogen Director Sells All Shares After Option Exercise

Axogen Director John Johnson executed pre-planned sales of all his common stock and exercised options, reducing his direct beneficial ownership to zero.

Summary

• Director John Johnson engaged in a series of transactions on December 8 and 9, 2025, under a Rule 10b5-1 plan.
• On December 8, 2025, Johnson exercised options to acquire 11,891 shares of Axogen common stock at an exercise price of $6.30 per share.
• Concurrently, he sold 11,802 shares at a weighted average price of $31.26 and 11,891 shares at a weighted average price of $31.223.
• On December 9, 2025, Johnson exercised options to acquire an additional 8,545 shares at $6.30 per share.
• He then sold these 8,545 shares at a weighted average price of $29.982, along with his remaining 13,141 directly held shares at the same weighted average price.
• Following these transactions, Johnson's direct beneficial ownership of Axogen common stock and derivative securities is zero.
• The stock options exercised were non-qualified options from the 2023 annual equity grant, which vested on September 1, 2024.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a director completely divesting their holdings, even though the transactions were pre-planned under a 10b5-1 plan and resulted in significant personal profit. Complete divestment can signal a lack of long-term commitment or belief in future appreciation.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales rather than a reaction to immediate, non-public information.
• The exercise price of the options was $6.30, while the shares were sold at significantly higher prices (ranging from $29.90 to $31.57), indicating a substantial profit for the director.

Negatives

• A director selling all of their common stock and derivative securities, even under a 10b5-1 plan, can be interpreted by some investors as a lack of long-term conviction in the company's future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the complete divestment by a director as a negative signal, potentially influencing their perception of the company's future prospects and stock value.

Key Dates

Recommendation

While the complete divestment by a director could be seen as a negative signal, the transactions were pre-planned under a Rule 10b5-1 plan, which mitigates the immediate negative interpretation of insider sentiment. The director realized substantial profits from exercising options and selling shares at significantly higher prices. Without additional information on the company's fundamentals or other market factors, a 'hold' recommendation is appropriate, advising investors to monitor future company performance and other insider activity.

Keywords

Axogen, AXGN, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transactions, 10b5-1 Plan, Equity Grant